Read news as it happens
Create a Rediffmail account
Subscribe via RSS
Bharat Biotech completes phase-III trials for nasal Covid vaccine
Bharat Biotech International Ltd (BBIL) on Monday said it has completed the phase-III and booster dose trials for its intranasal Covid-19 vaccine BBV154, and it has proven to be safe. Photograph:......
'Around 100 million doses will definitely be wasted'
'We are trying to salvage 50-100 million doses of Covishield with the latest drive on booster doses.' IMAGE: A Navi Mumbai Municipal Corporation worker administers the precautionary booster dose......
Millions of Covid vaccine doses are set to expire in India
Pune-based Serum Institute of India (SII) is sitting on 200 million doses of Covishield that were manufactured in December and are set to expire in September. The company is likely to destroy......
Govt panel recommends reducing Covid booster dose gap to 6 months
The Standing Technical Sub-Committee (STSC) of the National Technical Advisory Group on Immunisation (NTAGI) on Thursday recommended reducing the gap between the second and precaution doses of......
Nobody can be forced to get COVID-19 vaccines: SC
No individual can be forced to get vaccinated against COVID-19, the Supreme Court said on Monday and asked the Centre to make public data on the immunisation's adverse events. Photograph: PTI......
Reports of coal crisis baseless: Sitharaman
Amid reports of the ongoing coal shortage in the country, Finance Minister Nirmala Sitharaman stressed that there is no shortage and termed these as “absolutely baseless”, saying India......
Top Coverage News
US Presidential Elections 2016
Coming to India and making
Success in manufacturing is not just about being cheap - cheap labour, cheap land, cheap power...
India, through the eye of a camera
Commonwealth Games - 2014
The defence coverage of Rediff.com
Office email App
© 2022 Rediff.com